Skip to main content
. 2020 Sep;9(5):364–374. doi: 10.21037/acs-2020-surd-27

Table 2. Patient demographics and outcome.

Characters SURD (N=2,426) RDV (N=1,650) P value
Pooled value Number of patients Number of studies Pooled value Number of patients Number of studies
Age (95% CI) 77.1 (76.8–77.4) 2,426 7 74.3 (73.1–75.6) 1,650 7 0.001
STS PROM (95% CI) 3.13 (2.38–3.88) 1,269 4 2.60 (2.46–2.76) 1,087 0.31
Number of concomitant procedure (%) 427 (17.6%) 2,426 7 449 (27.2%) 1,650 7 0.2
Number minimally invasive approach (%) 1,566 (67.2%) 2,335 5 795 (50.3%) 1,578 5 0.68
CPB time (95% CI) 80.39 (74.0–86.6) 2,426 7 93.4 (91.8–95.1) 1,650 7 <0.001
Cross-clamp time (95% CI) 50.8 (50.0–51.6) 2,426 7 63.6 (62.4–64.9) 1,650 7 <0.001
Number of strokes (%) 48 (2.3%) 2,122 6 40 (2.5%) 1,548 6 1.00
Number of post-op PPM implantation (%) 187 (9.5%) 1,977 7 111 (6.7%) 1,649 7 0.06
Deaths (%) 51 (2.3%) 2,351 7 41 (2.5%) 1,647 7 1.00
Number of moderate + paravalvular leak (%) 17 (0.1%) 1,982 7 19 (1.3%) 1,418 7 0.84

CI, confidence interval; STS PROM, Society of Thoracic Surgeons Predictor of Operative Mortality; CPB, cardiopulmonary bypass; PPM, permanent pacemaker; SURD, sutureless rapid deployment valve; RDV, rapid deployment valve.